UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - immunosuppression
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Novel Lymphocyte Stimulation Assay To Quantify Immune Responses (UCLA Case No. 2022-079)
UCLA researchers in the Department of Medicine have developed lymphocyte stimulation assays to evaluate immune responses, supporting various clinical applications such as adjusting immunosuppressant drug levels and advancing COVID-19 vaccine development. The assay systems are reliable, cost-effective, and easy-to-perform, providing accurate assessments...
Published: 2/14/2025
|
Inventor(s):
Yusaku Shino
Keywords(s):
Antibody
,
biomarkers
,
cytokines
,
Immunity (Medical)
,
immunosuppression
,
Organ Transplant
Category(s):
Life Science Research Tools > Antibodies
,
Therapeutics > Immunology And Immunotherapy
Engineered T Cells Capable of Simultaneous Tumor Targeting and Alteration of Tumor Microenvironment Through Vasculature Normalization (UCLA Case No. 2023-264)
UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have built a series of chimeric antigen receptor (CAR)-T cells that target different antigens and secrete different anti-angiogenic proteins. Additionally, researchers also constructed bispecific CARs that respond to tumor antigen and pro-angiogenic molecules. BACKGROUND:...
Published: 2/14/2025
|
Inventor(s):
Yvonne Chen
Keywords(s):
Cancer
,
Cancer Immunotherapy
,
CAR-T cell therapy
,
immunosuppression
,
Immunosuppressive Drug
,
Immunotherapy
,
solid tumors
,
Tumor microenvironment
,
tumor vasculature
,
VEGF
Category(s):
Therapeutics > Oncology